These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 23058346)
1. The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study. Reichenbach A; Al-Hiti H; Malek I; Pirk J; Goncalvesova E; Kautzner J; Melenovsky V Int J Cardiol; 2013 Sep; 168(1):60-5. PubMed ID: 23058346 [TBL] [Abstract][Full Text] [Related]
2. Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation. Hefke T; Zittermann A; Fuchs U; Schulte-Eistrup S; Gummert JF; Schulz U Thorac Cardiovasc Surg; 2012 Feb; 60(1):26-34. PubMed ID: 21432755 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and clinical benefits associated with chronic sildenafil therapy in advanced heart failure: experience of the Montréal Heart Institute. Potter BJ; White M; Carrier M; Pellerin M; L'Allier PL; Pelletier GB; Racine N; Ducharme A Can J Cardiol; 2012; 28(1):69-73. PubMed ID: 22129489 [TBL] [Abstract][Full Text] [Related]
4. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618 [TBL] [Abstract][Full Text] [Related]
5. Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation. Pons J; Leblanc MH; Bernier M; Cantin B; Bourgault C; Bergeron S; Proulx G; Morin J; Nalli C; O'Connor K; Chateauvert N; Sénéchal M J Heart Lung Transplant; 2012 Dec; 31(12):1281-7. PubMed ID: 23127754 [TBL] [Abstract][Full Text] [Related]
6. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition. Botha P; Parry G; Dark JH; Macgowan GA J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary artery hypertension in heart transplant recipients: how much is too much? De Santo LS; Romano G; Maiello C; Buonocore M; Cefarelli M; Galdieri N; Nappi G; Amarelli C Eur J Cardiothorac Surg; 2012 Nov; 42(5):864-9; discussion 869-70. PubMed ID: 22402452 [TBL] [Abstract][Full Text] [Related]
8. Benefit of prostaglandin infusion in severe heart failure: preliminary clinical experience of repetitive administration. Serra W; Musiari L; Ardissino D; Gherli T; Montanari A Int J Cardiol; 2011 Jan; 146(1):e10-5. PubMed ID: 19176262 [TBL] [Abstract][Full Text] [Related]
9. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension. Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849 [TBL] [Abstract][Full Text] [Related]
10. Acute effect of sildenafil on central hemodynamics in mechanically ventilated patients with WHO group III pulmonary hypertension and right ventricular failure necessitating administration of dobutamine. Karakitsos D; Papanikolaou J; Karabinis A; Alalawi R; Wachtel M; Jumper C; Alexopoulos D; Davlouros P Int J Cardiol; 2013 Aug; 167(3):848-54. PubMed ID: 22386699 [TBL] [Abstract][Full Text] [Related]
11. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy. Bhatia S; Frantz RP; Severson CJ; Durst LA; McGoon MD Mayo Clin Proc; 2003 Oct; 78(10):1207-13. PubMed ID: 14531479 [TBL] [Abstract][Full Text] [Related]
12. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation]. Liu MZ; Wang JH; Du J; Huang J; Li LH Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149 [TBL] [Abstract][Full Text] [Related]
13. Prevention of right heart failure after left ventricular assist device implantation by phosphodiesterase 5 inhibitor. Hamdan R; Mansour H; Nassar P; Saab M Artif Organs; 2014 Nov; 38(11):963-7. PubMed ID: 24689700 [TBL] [Abstract][Full Text] [Related]
14. [Short-term survival after heart transplantation: the relationships between preoperative hemodynamics, organ function and postoperative clinical events]. Frigerio M; Gronda E; Danzi GB; Mangiavacchi M; Oliva F; Quaini E; Trotta E; De Vita C; Pellegrini A G Ital Cardiol; 1995 Jan; 25(1):1-9. PubMed ID: 7642005 [TBL] [Abstract][Full Text] [Related]
15. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566 [TBL] [Abstract][Full Text] [Related]
16. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure. Maruszewski M; Zakliczyński M; Przybylski R; Kucewicz-Czech E; Zembala M Transplant Proc; 2007 Nov; 39(9):2850-2. PubMed ID: 18021999 [TBL] [Abstract][Full Text] [Related]
17. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial. Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181 [TBL] [Abstract][Full Text] [Related]
18. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil. Melenovsky V; Al-Hiti H; Kazdova L; Jabor A; Syrovatka P; Malek I; Kettner J; Kautzner J J Am Coll Cardiol; 2009 Aug; 54(7):595-600. PubMed ID: 19660688 [TBL] [Abstract][Full Text] [Related]
19. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial. Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003 [TBL] [Abstract][Full Text] [Related]
20. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant. Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]